Analyst Price Target is C$6.00
▲ +7.33% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for NorthWest Health Prop Real Est Inv Trust in the last 3 months. The average price target is C$6.00, with a high forecast of C$7.00 and a low forecast of C$5.50. The average price target represents a 7.33% upside from the last price of C$5.59.
Current Consensus is
Moderate Buy
The current consensus among 2 polled investment analysts is to moderate buy stock in NorthWest Health Prop Real Est Inv Trust. This rating has held steady since November 2025, when it changed from a Buy consensus rating.